[HTML][HTML] Hybrid drugs—a strategy for overcoming anticancer drug resistance?

M Szumilak, A Wiktorowska-Owczarek, A Stanczak - Molecules, 2021 - mdpi.com
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?

M Szumilak, A Wiktorowska-Owczarek… - Molecules (Basel …, 2021 - europepmc.org
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?

M Szumilak, A Wiktorowska-Owczarek… - …, 2021 - publicum.umed.lodz.pl
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?

M Szumilak, A Wiktorowska-Owczarek… - Molecules, 2021 - search.proquest.com
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

[PDF][PDF] Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance

M Szumilak, A Wiktorowska-Owczarek, A Stanczak - Molecules, 2021 - academia.edu
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?

M Szumilak… - Molecules (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

[PDF][PDF] Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance

M Szumilak, A Wiktorowska-Owczarek… - …, 2021 - pdfs.semanticscholar.org
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?

M Szumilak, A Wiktorowska-Owczarek… - …, 2021 - search.ebscohost.com
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

[HTML][HTML] Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?

M Szumilak, A Wiktorowska-Owczarek, A Stanczak - Molecules, 2021 - ncbi.nlm.nih.gov
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?

M Szumilak, A Wiktorowska-Owczarek… - …, 2021 - publicum.umed.lodz.pl
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …